Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index; 21 of the 24 sources its claims cite were checked for support.

Prospective examination of synthetic 5-methoxy-N,N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgment

Open access
Uthaug, Malin V, Lancelotta, Rafael, Szabo, Attila, Davis, Alan K, Riba, Jordi, Ramaekers, Johannes G · 2020 · Psychopharmacology

Abstract

Rationale: 5-methoxy-N,N-dimethyltryptamine is a psychotropic substance found in various plant and animal species and is synthetically produced. 5-methoxy-N,N-dimethyltryptamine is used in naturalistic settings for spiritual exploration, recreation, or to address negative affect and mood problems. However, scientific knowledge on the effects of 5-methoxy-N,N-dimethyltryptamine in humans is scarce. Objectives: The first objective was to assess the effects of inhalation of vaporized synthetic 5-methoxy-N,N-dimethyltryptamine on neuroendocrine markers. The second objective was to assess effects of the substance on affect and mindfulness. In addition, we assessed whether ratings of subjective measures were associated with changes in stress biomarkers (i.e., cortisol) and immune response (i.e., IL-6, CRP, IL-1β), as well as the acute psychedelic experience. Methods: Assessments (baseline, immediately post-session, and 7-day follow-up) were made in 11 participants. Salivary samples were collected at baseline and post-session and analyzed by high-sensitivity enzyme-linked immunosorbent assay (ELISA). Results: 5-methoxy-N,N-dimethyltryptamine significantly increased cortisol levels and decreased IL-6 concentrations in saliva immediately post-session. These changes were not correlated to ratings of mental health or the psychedelic experience. Relative to baseline, ratings of non-judgment significantly increased, and ratings of depression decreased immediately post-session and at follow-up. Ratings of anxiety and stress decreased from baseline to 7-day follow-up. Participant ratings of the psychedelic experience correlated negatively with ratings of affect and positively with ratings of non-judgment. Conclusion: Inhalation of vaporized synthetic 5-methoxy-N,N-dimethyltryptamine produced significant changes in inflammatory markers, improved affect, and non-judgment in volunteers. Future research should examine the effect of 5-methoxy-N,N-dimethyltryptamineamine with healthy volunteers in a controlled laboratory setting. © 2019, The Author(s).

Overview

CoChat Summary

TL;DR

In this prospective naturalistic study of 11 people inhaling vaporized synthetic 5-MeO-DMT, the session increased salivary cortisol and decreased salivary IL-6 immediately post-session, while also improving non-judgment and reducing depression, anxiety, and stress over time. The authors conclude the findings are promising but preliminary because the sample was very small and there was no placebo control.

Key findings

  • In 11 participants, 5-MeO-DMT significantly increased salivary cortisol immediately post-session (mean difference, MD = 0.21 μg/dL; p < 0.001) and significantly decreased salivary IL-6 (MD = 3.51 pg/mL; p < 0.001).
  • Relative to baseline, non-judgment increased immediately post-session (p = .017, Cohen’s d = 0.36) and remained increased in the abstract’s summary; depression decreased immediately post-session and at 7-day follow-up, while anxiety and stress decreased from baseline to 7-day follow-up.
  • The psychedelic experience was moderate: mean ego dissolution (EDI) was 51.84% (SD 29.49), and the top 5D-ASC subscales were experience of unity 53.82% (36.25), blissful state 51.35% (38.94), and disembodiment 49.58% (30.84).
  • Adverse effects were reported by 45.5% (N = 5) post-session and by 27.3% (N = 3) during the 7 days after the session.

Methods

  • Observational, prospective naturalistic study in Prague, where participants inhaled vapor from synthetic 5-MeO-DMT administered by a facilitator in one-on-one sessions.
  • Sample: 11 participants; 10 completed the 7-day follow-up. Baseline and immediate post-session assessments were collected on location, with salivary samples at baseline (30 min before) and post-session (within 1–1.5 h after).
  • Main analyses used repeated-measures ANOVA / linear mixed models across baseline, post-session, and follow-up; paired t tests for saliva ELISA data; and Pearson correlations between psychometric measures and biomarker changes.

Limitations

  • The authors explicitly note the small sample size, possible volunteer bias/social desirability, and lack of a placebo control group as limits to generalizability.
  • The setting was naturalistic rather than a controlled laboratory environment, which the paper itself says future research should address.
  • Evident from the text: only 10 participants completed follow-up, and biomarker measurements were limited to saliva collected at two time points, so longer-term and more controlled effects are not established.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1007/s00213-019-05414-w

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Frequency distribution of the experience of ego dissolution as assessed by the EDI post-session after inhalation of vaporized synthetic 5-MeO-DMT (left panel). Mean ratings (range 0–100%) of the psychedelic experience as assessed with the 5D ASC subscales (upper right panel) and dimensions (lower right panel) after inhalation of vaporized synthetic 5-MeO-DMT
Fig. 1 Frequency distribution of the experience of ego dissolution as assessed by the EDI post-session after inhalation of vaporized synthetic 5-MeO-DMT (left panel). Mean ratings (range 0–100%) of the psychedelic experience as assessed with the 5D ASC subscales (upper right panel) and dimensions (lower right panel) after inhalation of vaporized synthetic 5-MeO-DMTCC BY · PubMed Central
Fig. 2 Effect of 5-MeO-DMT on salivary neuroendocrine and immune markers. Saliva samples were collected before (baseline) and 1–1.5 h after (post) the inhalation of vaporized synthetic 5-MeO-DMT and were analyzed by ELISA. Results are shown as mean ± SEM. Asterisks (****) represent p values < 0.001; n.s. means no statistical significance
Fig. 2 Effect of 5-MeO-DMT on salivary neuroendocrine and immune markers. Saliva samples were collected before (baseline) and 1–1.5 h after (post) the inhalation of vaporized synthetic 5-MeO-DMT and were analyzed by ELISA. Results are shown as mean ± SEM. Asterisks (****) represent p values < 0.001; n.s. means no statistical significanceCC BY · PubMed Central
Fig. 3 Mean (SE) ratings of anxiety (upper left panel), depression (upper right panel), and stress (bottom right panel) as assessed by DASS-21 (upper panel), and ratings of non-judgment (lower left panel) as measured by FFMQ-39. Before (0), post-session (1), and 7 days after (7) inhalation of vaporized synthetic 5-MeO-DMT (* p ≤ .05)
Fig. 3 Mean (SE) ratings of anxiety (upper left panel), depression (upper right panel), and stress (bottom right panel) as assessed by DASS-21 (upper panel), and ratings of non-judgment (lower left panel) as measured by FFMQ-39. Before (0), post-session (1), and 7 days after (7) inhalation of vaporized synthetic 5-MeO-DMT (* p ≤ .05)CC BY · PubMed Central
Fig. 4 Pearson’s correlations between ego dissolution and affect and non-judgment ratings post-session (upper panel), as well as affect and non-judgment ratings at follow-up (lower panel) after inhalation of vaporized synthetic 5-MeO-DMT
Fig. 4 Pearson’s correlations between ego dissolution and affect and non-judgment ratings post-session (upper panel), as well as affect and non-judgment ratings at follow-up (lower panel) after inhalation of vaporized synthetic 5-MeO-DMTCC BY · PubMed Central

Verification

Claims the paper makes

16 Valid · 1 Not valid · 2 Not checked · 62 Own results and interpretations

42 more claims · 2 with their cited sources checked

Create a free account to see all 81 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 20
  • It may state two separate claims as one. 21

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 56 references

Research works printed but not linked: 3

  1. Dittrich A, Lamparter D, Maurer M (2010) 5D-ASC: questionnaire for the assessment of altered states of consciousness. A short introduction. PSIN PLUS, Zurich
  2. IBM SPSS (2016) Statistics for windows. IBM Corp, Armonk, NY
  3. Shulgin A, Shulgin A (1997) TIHKAL: the continuation (Vol. 546). Transform Press, Berkeley

Cited by

See all 119

Metadata

Authors
Uthaug, M. V., Lancelotta, R., Szabo, A., Davis, A. K., Riba, J., & Ramaekers, J. G.
Affiliations
  • Maastricht University (NL)
  • Johns Hopkins University (US)
Corresponding author
  • Uthaug, Malin V
  • Ramaekers, Johannes G
Venue
Psychopharmacology
Published
2019-12-10
Volume
237
Issue
3
Pages
773-785
ISSN
  • 0033-3158 (ISSN-L)
  • 1432-2072
OpenAlex
W2996702784
Cited by
117
References
56
Citations by year
2026: 7 · 2025: 16 · 2024: 14 · 2023: 37 · 2022: 19 · 2021: 16 · 2020: 6 · 2019: 1
FWCI
12.25
Type
journal article
Language
en
Open access
Licence
Locations
  • Psychopharmacology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research Publications (Maastricht University) (submittedVersion, cc-by)
  • Research Publications (Maastricht University) (submittedVersion, other-oa)
Funders
National Institutes of Health (#T32DA07209)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
Keywords
5-MeO-DMT, vapor inhalation, salivary cortisol, interleukin-6, inflammatory markers, non-judgment, affect, depression, anxiety, stress, mindfulness, neuroendocrine response
MeSH terms
Administration, Inhalation, Adult, Affect, N,N-Dimethyltryptamine, Female, Hallucinogens, Humans, Hydrocortisone, Judgment, Male, Prospective Studies, Psychotropic Drugs, Saliva, Interleukin-6, Mindfulness

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prospective examination of synthetic 5-methoxy-N,N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgment. https://app.cochat.ai/papers/10.1007/s00213-019-05414-w
The paper
Uthaug, M. V., Lancelotta, R., Szabo, A., Davis, A. K., Riba, J., & Ramaekers, J. G. (2020). Prospective examination of synthetic 5-methoxy-N,N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgment. Psychopharmacology. https://doi.org/10.1007/s00213-019-05414-w

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.